The Newsroom    Published Thursday, Jun. 22, 2006, 1:46 PM
Print   |   
« Back   |   

Study Questions Choice of Hormone Therapy for Prostate Cancer

Forbes Magazine (Internet / Print) 06/22/06 http://www.forbes.com/forbeslife/health/feeds/hscout/2006/06/21/hscout533354.html Androgen deprivation therapy, an effective but costly and potentially toxic treatment, is often used to treat advanced prostate cancer. But a new study suggests that a patient's choice of physician, rather than the stage of his cancer, may determine whether or not he gets the treatment. Researchers at the University of Texas Medical Branch at Galveston studied the treatment histories of nearly 62,000 men from a Medicare database, age 65 and older, who were diagnosed with prostate cancer. They also looked at data on the patients' 1,802 urologists and the frequency with which they prescribed androgen deprivation therapy. The therapy, which prevents production of cancer-promoting steroid androgens in cells, is used in approximately half of all prostate cancers, typically for more advanced or metastatic tumors. (This HealthDay article has appeared throughout the United States on TV and in Print.)



Follow Us:
The Newsroom is a service provided by the Office of Public Affairs  •  Questions or Comments?